Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avinashnarayan Venkatanarayan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Cell Reports|February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growthAvinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2014
Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8Deepavali Chakravarti, Xiaohua Su, Min Soon Cho, et al.
Cancer|April 24, 2019
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumorsPreethi H Gunaratne, Yinghong Pan, Abhi K Rao, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Journal of Medicinal Chemistry|October 22, 2024
Discovery and Synthesis of Heterobifunctional Degraders of Rearranged during Transfection (RET) KinaseJennifer X Qiao, David Williams, Patrice Gill, et al.
Nature|May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanomaIvana Yen, Frances Shanahan, Jeeyun Lee, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Cell Reports|February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growthAvinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2014
Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8Deepavali Chakravarti, Xiaohua Su, Min Soon Cho, et al.
Cancer|April 24, 2019
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumorsPreethi H Gunaratne, Yinghong Pan, Abhi K Rao, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Journal of Medicinal Chemistry|October 22, 2024
Discovery and Synthesis of Heterobifunctional Degraders of Rearranged during Transfection (RET) KinaseJennifer X Qiao, David Williams, Patrice Gill, et al.
Nature|May 6, 2021
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanomaIvana Yen, Frances Shanahan, Jeeyun Lee, et al.
Pageof 2